4.6 Article

Rapid quantification of the malaria biomarker hemozoin by improved biocatalytically initiated precipitation atom transfer radical polymerizations

期刊

ANALYST
卷 145, 期 23, 页码 7741-7751

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d0an00976h

关键词

-

资金

  1. Swiss National Science Foundation [PP00P2_144697, PP00P2_172927, PZ00P2_179865]
  2. National Centre of Competence in Research (NCCR) Bio-Inspired Materials
  3. BRIDGE Proof-of-Concept grant [20B1-1_173771]
  4. Novartis Foundation for Biological-Medical Research [16A025]
  5. Gebert Ruf Foundation [GRS086/17]
  6. Swiss National Science Foundation (SNF) [PZ00P2_179865, 20B1-1_173771, PP00P2_172927] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

The fight against tropical diseases such as malaria requires the development of innovative biosensing techniques. Diagnostics must be rapid and robust to ensure prompt case management and to avoid further transmission. The malaria biomarker hemozoin can catalyze atom transfer radical polymerizations (ATRP), which we exploit in a polymerization-amplified biosensing assay for hemozoin based on the precipitation polymerization of N-isopropyl acrylamide (NIPAAm). The reaction conditions are systematically investigated using synthetic hemozoin to gain fundamental understanding of the involved reactions and to greatly reduce the amplification time, while maintaining the sensitivity of the assay. The use of excess ascorbate allows oxygen to be consumed in situ but leads to the formation of reactive oxygen species and to the decomposition of the initiator 2-hydroxyethyl 2-bromoisobutyrate (HEBIB). Addition of sodium dodecyl sulfate (SDS) and pyruvate results in better differentiation between the blank and hemozoin-containing samples. Optimized reaction conditions (including reagents, pH, and temperature) reduce the amplification time from 37 +/- 5 min to 3 +/- 0.5 min while maintaining a low limit of detection of 1.06 ng mL(-1). The short amplification time brings the precipitation polymerization assay a step closer to a point-of-care diagnostic device for malaria. Future efforts will be dedicated to the isolation of hemozoin from clinical samples.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据